Studies on thalassemia. I. An extracorpuscular defect in thalassemia major. II. The effects of splenectomy in thalassemia major with an associated acquired hemolytic anemia.
نویسندگان
چکیده
Normal red blood cells, when transfused to patients with thalassemia, have been shown to have a normal life span (1-4). It has also been demonstrated that transfused erythrocytes from donors with thalassemia major rapidly disappear from the circulation of normal recipients (2, 4). This evidence supports the contention that the hemolytic component of the anemia in thalassemia is due to an intracorpuscular defect, as is the case in congenital spherocytic anemia (5) and in sickle cell anemia (6). We have had the opportunity to observe repeatedly approximately 20 children with thalassemia major during the past five years. All of these subjects have required blood transfusions to alleviate such recurring symptoms as listlessness, irritability, anorexia, fatigue, palpitations, weakness or dizziness. It was evident after review of the transfusion records that many of these children were receiving 500 cc. supplements of blood, or the equivalent in packed erythrocytes, at very short intervals, i.e., every ten days or every 25 days. Since (a) prior to transfusion, hemoglobin and hematocrit levels in any one patient were fairly constant (and definitely not rising over a period of several years), and since (b) there was no external loss of blood, it seemed logical to assume that the transfused blood was not surviving the expected
منابع مشابه
Influence of splenectomy on immunoglobulins and complement components in major thalassemia
Abstract Introduction: Thalassemia is the most common hereditary anemia in Iran. The aim of this study was to evaluate the humoral immune system and assess the effect of splenectomy on the serum level of immunoglobulins IgG, IgM, and IgA and complement components in patients with major thalassemia. Materials and Methods: This interventional semi-experimental study (before-after) was performed...
متن کاملSide effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
Background Sickle hemoglobin is the most common abnormal hemoglobin in the United States. Hemoglobin S arises as a result of a single amino acid substitution (glutamic acid to valin at position 6 of the β-globine chain). The presence of fetal hemoglobin (HbF) plays a relatively protective role since a significant amount of HbF interferes with HbS polymerization, the pathogenesis mechanism of ...
متن کاملگزارش یک مورد ترومبوز ورید پورت به دنبال طحال برداری در یک بیمار24 ساله مبتلا به تالاسمی ماژور
Introduction: Beta thalassemia major is a severe hemolytic anemia due to inadequate synthesis of beta chain globin. Splenomegaly secondary to extramedullary hematopoiesis and iron overload is one of the most prominent findings and makes splenectomy inevitable in majority of these patients. For many reasons these patients are at risk of hypercoagulation. Portal vein thrombosis is a rare cons...
متن کاملPrevalence of HCVAb and HBsAg in Patients with Beta-thalassemia Major in Amirkola Thalassemia Center
Background and purpose: Beta-thalassemia major is a genetic disorder with known globin defect that leads to chronic hemolytic anemia. Due to the need for recurrent blood transfusion, the risk of infectious diseases such as hepatitis is higher in these patients. Materials and methods: This cross-sectional study recruited 518 patients with thalassemia major in Amirkola Thalassemia Center, 2013-2...
متن کاملThe Splenectomy Effects on Lipid Profile and Glucose Metabolism in the Major Thalassemia Patients
Background: Splenectomy is a common treatment for beta thalassemia. It not only eliminates many complications by reducing the need for blood transfusion, but also causes new complications that threaten the patientschr('39') health. The aim of this study was to determine if splenectomy could alter the lipid profile and glucose metabolism in beta thalassemia major patients. Methods: In this case-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of clinical investigation
دوره 32 12 شماره
صفحات -
تاریخ انتشار 1953